Literature DB >> 32336000

Clinical management of 52 consecutive retro-rectal tumours treated at a tertiary referral centre.

M Carpelan-Holmström1, L Koskenvuo1, C Haapamäki1, L Renkonen-Sinisalo1, A Lepistö1.   

Abstract

AIM: The aim of this single-institution study was to analyse the diagnostic methods, preoperative work-up and outcomes of 52 retro-rectal tumours.
METHOD: All patients treated for retro-rectal tumours from 2012 to 2017 were included.
RESULTS: Out of 52 patients, 40 (77%) were women. The median age of patients at the time of surgery was 43 (19-76) years, and 30 (58%) were asymptomatic at the time of diagnosis. All tumours were visible on magnetic resonance imaging (MRI) prior to surgery. The sensitivity and specificity for predicting malignancy on preoperative imaging for retro-rectal tumours were 25% and 98%, respectively. Forty-four procedures (85%) were performed using the perineal approach. The median hospital stay was 3 (1-18) days. There was no 30-day postoperative mortality. Eleven (21%) patients developed postoperative complications, mostly surgical site infections. Twenty-nine tumours (56%) were benign tailgut cysts. Four (8%) tumours were malignant and were considered to be removed with a tumour-free resection margin. Local recurrent disease was detected on MRI in 14 (27%) patients at a median of 1.05 (range 0.78-1.77) years after primary surgery. Only the multi-lobular shape of the tumour was found to be an independent risk factor for recurrence (P = 0.030).
CONCLUSION: A preoperative MRI is mandatory in order to plan the surgical strategy for retro-rectal tumours. Symptomatic, solid, large tumours should be removed because of the risk of malignancy. Minor cystic lesions with thin walls as well as asymptomatic recurrences of benign tumours are suitable to be followed conservatively. Colorectal Disease
© 2020 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Retro-rectal tumour; clinical management; diagnosis; follow-up; histology; presacral tumour

Year:  2020        PMID: 32336000     DOI: 10.1111/codi.15080

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  5 in total

1.  Presacral Tumor: Insights From a Decade's Experience of This Rare and Diverse Disease.

Authors:  Zeyu Li; Min Lu
Journal:  Front Oncol       Date:  2021-03-16       Impact factor: 6.244

2.  Risk factors for perioperative complications in laparoscopic surgeries of retrorectal cystic lesions.

Authors:  Pei-Pei Wang; Chen Lin; Jiao-Lin Zhou; Kai-Wen Xu; Hui-Zhong Qiu; Bin Wu
Journal:  World J Gastrointest Surg       Date:  2021-12-27

3.  Primary malignant tumours and malignant transformation of cysts in the retrorectal space: MRI diagnosis and treatment outcomes.

Authors:  Jing Gong; Yumeng Xu; Yan Zhang; Lichao Qiao; Haixia Xu; Ping Zhu; Bolin Yang
Journal:  Gastroenterol Rep (Oxf)       Date:  2022-09-20

Review 4.  Retrorectal tumors: A challenge for the surgeons.

Authors:  Bengi Balci; Alp Yildiz; Sezai Leventoğlu; Bulent Mentes
Journal:  World J Gastrointest Surg       Date:  2021-11-27

5.  Robotic-Assisted Laparoscopic Resection of Tailgut Cysts.

Authors:  Ingmar F Rompen; Andreas Scheiwiller; Alain Winiger; Jürg Metzger; Jörn-Markus Gass
Journal:  JSLS       Date:  2021 Jul-Sep       Impact factor: 2.172

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.